Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody Syndrome
NCT01029587
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1
Enrollment
OTHER
Sponsor class
Conditions
Antiphospholipid Antibody Syndrome
End Stage Renal Disease
Interventions
DRUG:
Eculizumab
Sponsor
Johns Hopkins University